$140.54
0.39[0.28%]
Last update: 11:09AM Get Real Time Here
Ascendis Pharma
(NASDAQ:ASND)Ascendis Pharma Stock (NASDAQ:ASND), Earnings Estimates, EPS, and Revenue
Ascendis Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 7
EPS
$-1.660
Quarterly Revenue
$148.2M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$266.7M
Analyze the earnings history of Ascendis Pharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/02/2024 | PM | ASND | Q1 | -$2.13 | — | — | — | $36.05M | — | — | — | Get Alert |
| 02/07/2024 | PM | ASND | Q4 | -$3.78 | -$2.15 | -$1.66 | 22.79% | $23.37M | $97.02M | $148.22M | 52.77% | Get Alert |
| 11/07/2023 | PM | ASND | Q3 | -$3.05 | -$2.75 | -$3.13 | -13.82% | $15.41M | $52.70M | $52.28M | -0.79% | Get Alert |
| 09/05/2023 | PM | ASND | Q2 | -$1.56 | -$2.68 | -$2.35 | 1231.34% | $6.57M | $41.73M | $51.66M | 2378.38% | Get Alert |
| 04/27/2023 | PM | ASND | Q1 | -$2.48 | — | -$2.13 | — | $7.67M | — | $36.05M | — | Get Alert |
| 02/16/2023 | PM | ASND | Q4 | -$2.14 | — | -$3.78 | — | $5.60M | — | $23.37M | — | Get Alert |
| 11/02/2022 | PM | ASND | Q3 | -$1.73 | -$2.48 | -$3.05 | -22.98% | $1.31M | — | $15.41M | — | Get Alert |
| 08/10/2022 | PM | ASND | Q2 | -$3.01 | -$2.17 | -$1.56 | 28.11% | $1.23M | $5.92M | $6.57M | 10.90% | Get Alert |
| 05/11/2022 | PM | ASND | Q1 | -$1.41 | — | -$2.48 | — | $899.60K | — | $7.67M | — | Get Alert |
| 03/02/2022 | PM | ASND | Q4 | -$3.15 | -$2.63 | -$2.14 | 18.63% | $637.88K | $2.98M | $5.60M | 87.95% | Get Alert |
| 11/10/2021 | PM | ASND | Q3 | -$2.70 | — | -$1.73 | — | $3.22B | — | $1.31M | — | Get Alert |
| 08/25/2021 | PM | ASND | Q2 | -$2.17 | -$2.75 | -$3.01 | -9.45% | $1.58M | $1.46M | $1.23M | -15.68% | Get Alert |
| 05/27/2021 | PM | ASND | Q1 | -$1.46 | -$2.08 | -$1.41 | 32.21% | $2.45M | $2.30M | $899.60K | -60.89% | Get Alert |
| 03/10/2021 | PM | ASND | Q4 | -$1.89 | -$1.83 | -$3.15 | -72.13% | $2.78M | $1.99M | $637.88K | -67.95% | Get Alert |
| 11/11/2020 | PM | ASND | Q3 | -$0.58 | -$1.86 | -$2.70 | -45.16% | $2.24M | $1.66M | $3.22M | 94.10% | Get Alert |
| 08/27/2020 | PM | ASND | Q2 | -$1.39 | -$1.70 | -$2.17 | -27.65% | $3.56M | $2.53M | $1.58M | -37.51% | Get Alert |
| 05/19/2020 | PM | ASND | Q1 | -$1.38 | -$1.50 | -$1.46 | 2.67% | $6.01M | $2.07M | $2.45M | 18.55% | Get Alert |
| 04/01/2020 | PM | ASND | Q4 | -$0.85 | -$1.19 | -$1.89 | -58.82% | $11.78M | $1.25M | $2.78M | 122.64% | Get Alert |
| 11/18/2019 | PM | ASND | Q3 | -$0.92 | — | -$0.58 | — | $22.80K | — | $2.44M | — | Get Alert |
FAQ
When is Ascendis Pharma (NASDAQ:ASND) reporting earnings?
Ascendis Pharma (ASND) is scheduled to report earnings on May 2, 2024. The last reported earnings were for reported on February 7, 2024 for Q4.
What were the latest earnings per share (EPS) for Ascendis Pharma (NASDAQ:ASND)?
The Actual EPS was $-1.66, which beat the estimate of $-2.15.
What were Ascendis Pharma’s (NASDAQ:ASND) revenues?
The Actual Revenue was $148.2M, which beat the estimate of $97M.
Browse earnings estimates, EPS, and revenue on all stocks.